ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 20 filers reported holding ELIEM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,519 | -77.0% | 121,110 | -75.5% | 0.10% | -77.3% |
| Q2 2023 | $1,383,449 | -1.8% | 494,089 | +1.7% | 0.43% | -26.5% |
| Q1 2023 | $1,409,270 | -6.2% | 485,955 | +18.8% | 0.58% | +35.3% |
| Q4 2022 | $1,501,771 | +15.6% | 409,202 | +1.8% | 0.43% | -2.1% |
| Q3 2022 | $1,299,000 | -39.7% | 402,088 | -43.6% | 0.44% | -33.8% |
| Q2 2022 | $2,153,000 | +190.6% | 713,009 | +707.7% | 0.66% | +116.0% |
| Q1 2022 | $741,000 | – | 88,279 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,658,170 | $4,808,693 | 4.16% |
| RA Capital Management | 13,150,849 | $38,137,462 | 0.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 485,955 | $1,409,270 | 0.58% |
| Atom Investors LP | 78,886 | $228,769 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 673,684 | $1,953,684 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $160,147 | 0.00% |
| Chicago Partners Investment Group LLC | 18,520 | $52,412 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,706 | $86 | 0.00% |
| NORTHERN TRUST CORP | 11,247 | $32,616 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |